Form 4: Amgen EVP, Operations, Esteban Santos, Reports Changes in Beneficial Ownership

Esteban Santos, EVP of Operations at Amgen, reports a transaction involving common stock and derivative securities, including the acquisition of shares under the company's 401(k) plan and disposition of shares for tax purposes.

Summary

• On May 5, 2024, Esteban Santos, EVP of Operations at Amgen, filed a Form 4 to report changes in beneficial ownership of Amgen stock.
• The reported transactions include the disposition of 617 shares of common stock at a price of $311.29 per share to cover tax obligations.
• Santos also reported owning 68,307 shares of common stock directly and 856.6105 shares indirectly through the company's 401(k) plan.
• The direct holdings include Restricted Stock Units (RSUs) that will vest in future years.
• The report also mentions Dividend Equivalents (DEs) credited to unvested RSUs, which will be paid out in shares of Amgen's common stock.

Sentiment

Score: 5

Explanation: The sentiment is neutral as it is a standard regulatory filing reporting insider transactions. There is no indication of positive or negative sentiment towards the company's performance.

Positives

• The reporting person continues to hold a significant number of shares in the company, indicating confidence in Amgen's future.

Industry Context

Form 4 filings are a routine part of corporate governance, providing transparency into the transactions of company insiders. This filing indicates the transactions of a key executive at Amgen.

Comparison to Industry Standards

• Executive compensation and stock ownership are common across the pharmaceutical industry.
• Companies like Johnson & Johnson, Pfizer, and Merck also have similar equity compensation plans for their executives.
• The vesting schedules and terms of the RSUs are likely comparable to industry standards for executive compensation.

Stakeholder Impact

• The filing provides transparency to shareholders regarding insider transactions.
• The transactions themselves are unlikely to have a significant impact on stakeholders.

Key Dates